Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Toulmonde

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|January 6, 2018
PD-1 inhibition in sarcoma still needs investigationMaud Toulmonde, Antoine Italiano
Bulletin Du Cancer|March 6, 2026
[Vimseltinib in non-resecable tenosynovial giant cell tumor]Mathieu De Smet, Maud Toulmonde
La Revue Du Praticien|January 23, 2026
[Sarcoma: a plural entity]Thibaud Valentin, Nicolas Penel, Maud Toulmonde
Experimental and Therapeutic Medicine|September 21, 2012
Salvage chemotherapy for hormone-refractory prostate cancer: Association of Adriamycin and ifosfamideMaud Toulmonde, Pascal Démolis, Nadine Houédé
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Circulating tumour DNA sequencing reveal mechanisms of resistance to BRAF-targeted therapies in BRAF-mutated gastrointestinal stromal tumourMariella Spalato Ceruso, Maud Toulmonde, Laura Blouin, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2016
Hepatitis B reactivation during everolimus treatmentOlivier Mir, Maud Toulmonde, Romain Coriat, et al.
Frontiers in Medicine|April 24, 2023
Insulin amyloidosis: A case reportArthur Dubernet, Maud Toulmonde, Magali Colombat, et al.
European Journal of Radiology|October 22, 2020
Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitorsAmandine Crombé, Michèle Kind, Maud Toulmonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomasMaud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Anti-Cancer Drugs|September 2, 2017
Clinical activity of eribulin in advanced desmoplastic small round-cell tumorSheik Emambux, Michele Kind, Francois Le Loarer, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|January 6, 2018
PD-1 inhibition in sarcoma still needs investigationMaud Toulmonde, Antoine Italiano
Bulletin Du Cancer|March 6, 2026
[Vimseltinib in non-resecable tenosynovial giant cell tumor]Mathieu De Smet, Maud Toulmonde
La Revue Du Praticien|January 23, 2026
[Sarcoma: a plural entity]Thibaud Valentin, Nicolas Penel, Maud Toulmonde
Experimental and Therapeutic Medicine|September 21, 2012
Salvage chemotherapy for hormone-refractory prostate cancer: Association of Adriamycin and ifosfamideMaud Toulmonde, Pascal Démolis, Nadine Houédé
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Circulating tumour DNA sequencing reveal mechanisms of resistance to BRAF-targeted therapies in BRAF-mutated gastrointestinal stromal tumourMariella Spalato Ceruso, Maud Toulmonde, Laura Blouin, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2016
Hepatitis B reactivation during everolimus treatmentOlivier Mir, Maud Toulmonde, Romain Coriat, et al.
Frontiers in Medicine|April 24, 2023
Insulin amyloidosis: A case reportArthur Dubernet, Maud Toulmonde, Magali Colombat, et al.
European Journal of Radiology|October 22, 2020
Impact of CT-based body composition parameters at baseline, their early changes and response in metastatic cancer patients treated with immune checkpoint inhibitorsAmandine Crombé, Michèle Kind, Maud Toulmonde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Quality of randomized controlled trials reporting in the treatment of sarcomasMaud Toulmonde, Carine Bellera, Simone Mathoulin-Pelissier, et al.
Anti-Cancer Drugs|September 2, 2017
Clinical activity of eribulin in advanced desmoplastic small round-cell tumorSheik Emambux, Michele Kind, Francois Le Loarer, et al.
Pageof 10